BioCryst Pharmaceuticals,Inc. (BCRX)

[Fress]

Company is going to drop the hammer soon Corona virus update on Galidesivir
This nucleoside RNA polymerase inhibitor disrupts the viral replication process and has the potential to fight multiple viral threats at once.

Galidesivir (BCX4430) is a broad-spectrum antiviral in advanced development under the Animal Rule for the treatment of viruses that pose a threat to health and national security. A Phase 1 clinical safety and pharmacokinetics study in healthy subjects has been completed, and in animal studies, galidesivir has demonstrated survival benefits against a variety of serious pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. Galidesivir has also demonstrated broad-spectrum activity in vitro against more than 20 ribonucleic acid (RNA) viruses in nine different families, including filoviruses, togaviruses, bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.


120 million in cash Phase 1 already deep pipeline FDA approved drug. this is going to the next INO a much more solid company and treatment for Corona virus compared to INO not even in Phase 1 yet watch how this plays out. Book it



$BCRX